Unit
- Mast cell activation: Urticaria arises primarily from mast cell degranulation in the dermis, releasing histamine and other mediators such as leukotrienes and prostaglandins. This process leads to localized vasodilation, increased vascular permeability, and the characteristic wheal-and-flare response.
- IgE-dependent vs. IgE-independent triggers: Allergic urticaria involves cross-linking of IgE receptors on mast cells by allergens, while non-allergic forms result from direct mast cell activation by physical stimuli, medications, or endogenous factors like autoantibodies.
- Role of basophils: Basophils circulate in blood and can infiltrate urticarial lesions, contributing to mediator release. Their activation parallels mast cell degranulation and amplifies the inflammatory response.
- Histamine receptor subtypes: Histamine binds to H1 and H2 receptors on endothelial cells and sensory nerves. H1 receptor activation causes pruritus and vasodilation, while H2 receptors contribute to increased vascular permeability and gastric acid secretion.
- Other mediators: Besides histamine, tryptase, platelet-activating factor, and cytokines like IL-4 and TNF-alpha sustain the inflammatory cascade. These mediators account for the persistence of lesions beyond the initial histamine release.
- Dermal edema formation: Increased permeability of post-capillary venules allows plasma to leak into the dermis, creating the raised wheal. The surrounding erythema results from arteriolar dilation via axon reflexes.
- Duration and resolution: Individual wheals typically resolve within 24 hours. Chronic urticaria involves recurrent episodes over six weeks or longer, with ongoing mast cell activation possibly driven by autoimmune mechanisms.
- Angioedema association: Deeper dermal and subcutaneous edema can accompany urticaria, presenting as non-pitting swelling of lips, eyelids, and extremities. Angioedema involves similar mediators but occurs in the lower dermis and subcutaneous tissue.
- Diagnostic markers in chronic urticaria: Laboratory evaluation may include complete blood count, erythrocyte sedimentation rate, and C-reactive protein to exclude underlying causes. Autologous serum skin testing and basophil activation tests can help identify autoimmune urticaria, although these are not routinely performed in primary care. Additionally, thyroid autoantibodies and Helicobacter pylori screening may be considered in refractory cases.
- Role of autoantibodies in chronic spontaneous urticaria: Approximately 30 to 50 percent of patients have functional autoantibodies against the high-affinity IgE receptor or against IgE itself. These autoantibodies trigger mast cell degranulation in the absence of external allergens, leading to persistent wheal formation and resistance to standard antihistamine therapy.
- Impact of cytokines and chemokines: Beyond histamine, mediators such as IL-1, IL-6, and TNF-alpha contribute to the inflammatory microenvironment. Chemokines like CCL2 and CCL5 recruit additional immune cells, perpetuating lesion development. This cytokine network explains why some patients require advanced therapies beyond antihistamines, such as omalizumab.
- Genetic and environmental interactions: Family studies suggest a genetic predisposition to chronic urticaria, though no single gene has been identified. Environmental factors like infections, stress, and medications can trigger or exacerbate episodes. Understanding these interactions helps clinicians advise patients on trigger avoidance and lifestyle modifications.
Scope of Practice
Role: Primary Care Provider in Urticaria Management
Within scope:
- Recognizing clinical presentation of acute and chronic urticaria
- Performing basic history and physical examination to identify triggers
- Initiating first-line antihistamine therapy and monitoring response
- Distinguishing urticaria from other pruritic skin conditions
Outside scope:
- Performing skin biopsy for urticaria diagnosis
- Administering biologic therapies without specialty training
- Managing anaphylactic reactions beyond initial stabilization
- Prescribing immunosuppressive agents without consultation
Quick Revision
- Mast cell degranulation releases histamine and other mediators causing urticarial lesions.
- IgE-dependent and IgE-independent pathways both trigger mast cell activation.
- Histamine H1 and H2 receptors mediate pruritus, vasodilation, and edema.
- Wheals resolve within 24 hours; chronic urticaria persists beyond six weeks.
- Angioedema involves deeper tissue swelling and may accompany urticaria.